0RAA.L - Safe Orthopaedics SA

LSE - LSE Delayed price. Currency in EUR
0.2770
+0.0015 (+0.54%)
At close: 11:13AM BST
Stock chart is not supported by your current browser
Previous close0.2755
Open0.0000
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.0000 - 0.0000
52-week range
Volume0
Avg. volumeN/A
Market cap95,237
Beta (5Y monthly)1.78
PE ratio (TTM)N/A
EPS (TTM)-2.2180
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Globe Newswire

    Distribution agreements signed for the UK

    Distribution agreements signed for the UK Direct distribution in ScotlandIndirect distribution in England and Wales Éragny-sur-Oise, Fleurieux-sur-l'Arbresle, May 3rd, 2023 at 8:30 a.m. CET - Safe (FR001400F1V2 - ALSAF), a company specializing in the design, manufacture and marketing of ready-to-use technologies for back surgery, particularly safe for spinal fractures treated in emergency (the "Company") announces strategic sales agreement for the United Kingdom area. Since acquiring its distrib

  • Globe Newswire

    Safe group modifies its financial agenda

    Safe group modifies its financial agenda Éragny-sur-Oise, Fleurieux-sur-l'Arbresle, April 26th, 2023 at 8:30 a.m. CET - Safe (ALSAF), a company specializing in the design, manufacture and marketing of ready-to-use technologies for back surgery, particularly safe for spinal fractures treated in emergency (the "Company") announces the modiication of its financial agenda. François-Henri Reynaud, Chief Financial Officer of Safe Group, said: "Due to calendar constraints, we have decided to change the

  • Globe Newswire

    Safe group announces revenues of €1.5 million  in Q1 2023

    Safe group announces revenues of €1.5 million in Q1 2023 Safe Group consolidated sales up +6%. Safe Orthopaedics sales up strongly in France by +45% and in the UK by +25% Safe Medical sales up +20%. Éragny-sur-Oise, Fleurieux-sur-l'Arbresle, April 13th, 2023 at 5:45 p.m. CET - Safe (ALSAF), a company specializing in the design, manufacture and marketing of ready-to-use technologies for back surgery, particularly safe for spinal fractures treated in emergency (the "Company") announces its first q

  • Globe Newswire

    Conclusion of a new bond financing agreement for a maximum nominal amount of 29.9 million euros subject to conditions

    DISCLAIMER SAFE has set up this financing through OCEANE bonds with the Financial Investor who, after receiving the shares resulting from the conversion or exercise of these instruments, does not intend to remain a shareholder of the Company. The shares, resulting from the conversion or exercise of the above-mentioned securities, could be sold in the market at very short notice, which could create a strong downward pressure on the share price. Shareholders could suffer a loss of their invested c

  • Globe Newswire

    Effective date of the reverse split and first listing of the new consolidated shares

    Effective date of the reverse split and first listing of the new consolidated shares Completion of the reverse stock split and commencement of trading in the shares resulting from the reverse stock split Adjustment of the characteristics of the securities Reduction of the share capital Éragny-sur-Oise, Fleurieux-sur-l'Arbresle, February 27, 2023 at 5:45 p.m. CET - Safe (ALSAF), a company specializing in the design, manufacture and marketing of ready-to-use technologies for back surgery, particul

  • Globe Newswire

    Safe announces the reverse stock split of 1 new share for 3,700 existing shares

    Safe announces the reverse stock split of 1 new share for 3,700 existing shares ► Consolidation by way of exchange of 3,700 existing shares for 1 new share Start of the reverse split on Thursday, January 26, 2023 Consolidation takes effect on Monday, February 27, 2023 Suspension of the right to exercise the securities giving access to the capital from Tuesday, January 10, 2023 (inclusive) to Friday, February 24, 2023 (inclusive) Éragny-sur-Oise, France, January 12, 2023, 5:30 p.m. - Safe (FR0013

  • Globe Newswire

    Safe group announces consolidated annual sales of €5.9M, up 26%

    43% growth in direct sales for Safe Orthopaedics 20% growth in outsourced production sales 25,000 surgeries performed with Ready to Use technology Eragny-sur-Oise, France, January 11th, 2023 8:45 CET – Safe (FR0013467123 – ALSAF), a company specializing in the design, manufacturing and marketing of ready-to-use technologies for orthopedic surgeries, especially for back surgery, announces its 2022 annual revenue and its cash position. In thousands euroNon audited figures2021(12 months)2021(12 mon

  • Globe Newswire

    Safe announces the convocation of an extraordinary general meeting of the Company to be held on December 16, 2022

    Convocation of an extraordinary general meeting called to vote on the delegation of authority to the Company's Board of Directors to proceed with (i) the reverse stock split of the Company's shares by the allocation of one (1) new ordinary share with a par value of twelve (12) euros each against one thousand two hundred (1. 200) old ordinary shares, (ii) a reduction in the Company's share capital due to losses within the limit of 10% more or less of an amount of € 5,000,000 and (iii) an increase

  • Globe Newswire

    New Partners Wenzel Spine and Safe group join Forces during NASS, National American Spine Society, between October 11 and 14th 2022

    Co-promotion of Wenzel and Safe technologies in NASSInventory delivered to Wenzel Spine for the first cases Eragny-sur-Oise, France, Austin, Texas, USA, October 11th, 2022, 17h45 CET – Safe (FR0013467123 – ALSAF), a company specializing in the design, manufacturing, and marketing of ready-to-use technologies and services for spinal surgeries, and Wenzel Spine, a medical technology company focused on providing minimally invasive surgical and diagnostic solutions for the treatment of spinal disord

  • Globe Newswire

    Safe group announces its first semester financial results and Q3 sales

    H1 revenues up 30.4% compared to H1 2021EBITDA up 25% compared to H1 2021Q3 sales up 19% Eragny-sur-Oise, France, October 6th, 2022, 8:30 CET – Safe (FR0013467123 – ALSAF), a company specializing in the design, manufacturing, and marketing of single-use technologies for spinal surgeries, publishes its financial results for the six months ended June 30, 2022 as approved by the Board of Directors on October 5, 2022 and certified by the statutory auditors, as well as its revenues for the third quar

  • Globe Newswire

    Safe Group Announces Strategic Agreements with Wenzel Spine

    Distribution agreement in USA between Wenzel Spine and Safe OrthopaedicsManufacturing agreement between Wenzel Spine and Safe Medical Eragny-sur-Oise, France, October 3rd, 2022, 17h45 CET – Safe (FR0013467123 – ALSAF), a company specializing in the design, manufacturing, and marketing of single-use technologies for spinal surgeries, announces the signature of a distribution agreement of Safe Orthopaedics products in the USA by Wenzel Spine and a manufacturing agreement between Wenzel Spine and S

  • Globe Newswire

    Safe Medical announces the renewal of its ISO 13485 certification of its production site on an extended perimeter including clean rooms

    Renewal of certification for 3 yearsFull in-house productionQualification of 3D additive printing and start of production of first projects Eragny-sur-Oise, Fleurieux sur l’Arbresle, France, September 22th, 2022 5:45pm CET – Safe Medical , a subsidiary of Safe Group (FR0013467123 – ALSAF), a company specializing in the design, manufacturing and marketing of single-use technologies for spinal surgeries, delivering the safest treatment for spinal fractures urgently treated, announces the renewal o

  • Globe Newswire

    Safe Group announces half-year sales of €2.75 million,  27% growth

    Direct sales revenue of €1.183M in Q2 2022, up +59% compared to Q1 2022 Doubling of Sycamore and Hickory users Fully integrated production of SteriSpineTM technologies within the group Eragny-sur-Oise, Fleurieux sur l’Arbresle, France, July 7th, 2022 5:45pm CET – Safe (FR0013467123 – ALSAF), a company specializing in the design, manufacturing and marketing of single-use technologies for spinal surgeries, delivering the safest treatment for spinal fractures urgently treated, announces its half-ye